STE STERIS plc — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$208.93

Period return

-14.50 (-6.49%)

Volume

447.1K

2026-09-25O $208.11 H $209.69 L $207.21 C $208.93MA5 $208.69MA20 $216.25MA60 $222.69MA120 $218.4

6M · 127 barsYahoo Finance · USD2026-03-26 → 2026-09-25

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 06. 30.Medium3 months ago
Q1 2027 earnings
매출 14.9억. 세부 수치와 가이던스는 원문에서 확인하세요.
2026. 05. 15.High5 months ago
13F 기관 보유 변화 — Point72 Asset Management, L.P.
신규 편입 · 포트폴리오 비중 0.01%
2026. 05. 15.High5 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.09%
2026. 03. 31.Medium6 months ago
Q4 2026 earnings
매출 15.9억. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 12. 31.Medium9 months ago
Q3 2026 earnings
EPS 1.96 · 매출 15억. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 09. 30.Medium12 months ago
Q2 2026 earnings
EPS 1.94 · 매출 14.6억. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 06. 30.Mediumlast year
Q1 2026 earnings
EPS 1.79 · 매출 13.9억. 세부 수치와 가이던스는 원문에서 확인하세요.
2025. 03. 31.Mediumlast year
Q4 2025 earnings
매출 14.8억. 세부 수치와 가이던스는 원문에서 확인하세요.
2024. 12. 31.Medium2 years ago
Q3 2025 earnings
EPS 1.75 · 매출 13.7억. 세부 수치와 가이던스는 원문에서 확인하세요.
2024. 09. 30.Medium2 years ago
Q2 2025 earnings
EPS 1.51 · 매출 13.3억. 세부 수치와 가이던스는 원문에서 확인하세요.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
FY2027 Q1	2026. 06. 30.	Time TBD	—	—	—	—	$1.49B	Reported
FY2026 Q4	2026. 03. 31.	Time TBD	—	—	—	—	$1.59B	Reported
FY2026 Q3	2025. 12. 31.	Time TBD	—	$1.96	—	—	$1.5B	Reported
FY2026 Q2	2025. 09. 30.	Time TBD	—	$1.94	—	—	$1.46B	Reported

Research actions

Consensus PT $263.13 · 8 analysts

Research tab →

No research actions to show.

Key stats

As of FY2027Q1 · Source: SEC/DART + price data

Market cap$20.37B

Shares out.98M

PER26.21x

EPS (TTM)$7.97

PBR2.83x

BPS$73.91

Dividend/share—

Dividend yield—

Consensus—

Price target$263.13+25.9%

Target range$232.00 ~ $280.00· 8 analysts

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	479,146	$105.95M	0.09%	—	New position
2	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	84,707	$21.47M	0.03%	—	New position
3	Point72 Asset Management, L.P.	Point72 Asset Management, L.P.	35,800	$9.08M	0.01%	—	New position
4	Point72 Asset Management, L.P.	Point72 Asset Management, L.P.	32,930	$7.28M	0.01%	—	New position

Company info

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Sector: Healthcare
Industry: Medical Devices
HQ: Mentor, OH, United States
Fiscal year end: —
Employees: 17,937
IPO date: —

View details →

Top news

Stored first · Google News · Yahoo Finance (English)

Quarter

Date

Time

EPS est.

EPS actual

Surprise

Rev. est.

Rev. actual

Status

FY2027 Q1

2026. 06. 30.

Time TBD

—

$1.49B

Reported

FY2026 Q4

2026. 03. 31.

Time TBD

—

$1.59B

Reported

FY2026 Q3

2025. 12. 31.

Time TBD

—

$1.96

—

$1.5B

Reported

FY2026 Q2

2025. 09. 30.

Time TBD

—

$1.94

—

$1.46B

Reported

Institution

Mandate

Value

Weight

Change

Position

TWO SIGMA INVESTMENTS, LP

479,146

$105.95M

0.09%

—

New position

TWO SIGMA INVESTMENTS, LP

84,707

$21.47M

0.03%

—

New position

Point72 Asset Management, L.P.

35,800

$9.08M

0.01%

—

New position

Point72 Asset Management, L.P.

32,930

$7.28M

0.01%

—

New position